Kerrie Setiawan

Kerrie Setiawan has extensive experience in the pharmaceutical industry, working in various roles over the years. Kerrie started their career at Faulding Pharmaceuticals in 1996 as a Senior Development Chemist, where they led the development of innovative and generic formulations. Kerrie then joined Acrux as a Formulation Manager in 2004, where they were responsible for developing new transdermal formulations and overseeing preclinical product development.

In 2008, Setiawan became a member of 21st Century Education, a role which they held until 2013. Kerrie then joined Catalent Pharma Solutions in 2012 as a Manager of Stability & Analytical - Product Development, where they provided technical direction and consultation on analytical method development and stability testing.

Currently, Setiawan is the Head of Analytical Services at Blackmores Group since 2019. In this role, they lead the development and validation of analytical procedures for various products and provides technical direction for product registration and shelf life support.

Throughout their career, Setiawan has demonstrated expertise in analytical method development, formulation development, and ensuring compliance with regulatory standards. Kerrie has a strong track record of driving financial growth and customer satisfaction in their roles.

Kerrie Setiawan obtained a Ph.D. in Pharmaceutical Sciences from the University of Otago, where they attended from 1991 to 1995.